Qualigen Therapeutics Inc (QLGN)

Qualigen Therapeutics (QLGN) Financial Statements


Qualigen Therapeutics Financial Overview

Qualigen Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.528; its P/E ratio is -0.12; Qualigen Therapeutics is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ -3.23M$ 1.63M$ 1.61M$ 1.39M$ 1.44M
Gross Profit$ -3.23M$ 1.63M$ 1.61M$ 1.39M$ 1.44M
EBIT$ -1.19M$ -3.17M$ -4.82M$ -8.76M$ -4.06M
EBITDA$ -1.19M$ -3.05M$ -4.70M$ -8.65M$ -3.97M
Net Income Common Stockholders$ -2.45M$ -3.46M$ 5.57M$ -6.37M$ -3.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 400.00K$ 1.30M$ 4.41M$ 7.01M$ 6.61M
Total Assets$ 2.03M$ 13.15M$ 15.91M$ 19.08M$ 22.96M
Total Debt$ 1.30M$ 3.20M$ 3.00M$ 2.55M$ 2.51M
Net Debt$ 899.22K$ 1.90M$ -1.40M$ -4.45M$ -4.10M
Total Liabilities$ 4.14M$ 9.84M$ 9.71M$ 10.32M$ 7.04M
Stockholders Equity$ -2.10M$ 2.03M$ 4.87M$ 7.24M$ 12.15M
Cash Flow-
Free Cash Flow$ -5.70M$ -3.05M$ -2.80M$ -2.34M$ -3.18M
Operating Cash Flow$ -5.70M$ -3.00M$ -2.60M$ -2.25M$ -3.17M
Investing Cash Flow$ 235.40K$ -48.41K$ -198.01K$ -244.37K$ -11.26K
Financing Cash Flow$ -110.00K--$ 2.90M$ 3.31K
Currency in USD

Qualigen Therapeutics Earnings and Revenue History

Qualigen Therapeutics Debt to Assets

Qualigen Therapeutics Cash Flow

Qualigen Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis